Related Experiment Video

Updated: Jun 16, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Phenobarbital augments hypothermic neuroprotection

John D Barks1, Yi-Qing Liu, Yu Shangguan

  • 1Departments of Pediatrics and Neurology, University of Michigan, Ann Arbor, Michigan 48109, USA. jbarks@med.umich.edu

Pediatric Research
|January 26, 2010
PubMed

Insights

Early phenobarbital administration enhances therapeutic hypothermia's neuroprotective effects in neonatal hypoxic-ischemic encephalopathy models. This combination improves sensorimotor function and reduces brain damage, offering a promising strategy for infants.

Area of Science:

  • Neuroscience
  • Neonatal Medicine
  • Pharmacology

Background:

  • Seizures are a common complication in infants suffering from hypoxic-ischemic encephalopathy (HIE).
  • Adverse outcomes are frequently observed in infants with HIE, highlighting the need for effective neuroprotective strategies.
  • Therapeutic hypothermia is a standard treatment, but its efficacy may be limited without adjunctive therapies.

Purpose of the Study:

  • To investigate if early phenobarbital administration can enhance the neuroprotective effects of delayed-onset therapeutic hypothermia.
  • To test the hypothesis in a neonatal rodent model of cerebral hypoxia-ischemia.
  • To evaluate the impact on both early and late functional and neuropathological outcomes.

Main Methods:

  • A neonatal rat model was used, involving carotid ligation and subsequent hypoxic exposure.
  • Rats received either phenobarbital (40 mg/kg) or saline 15 minutes after hypoxia-ischemia.
  • Therapeutic hypothermia (30°C for 3 hours) was initiated 1 or 3 hours post-insult, followed by functional and neuropathological assessments.

Main Results:

  • Early assessments showed improved sensorimotor performance and reduced cortical damage in phenobarbital-treated groups.
  • Late outcome assessments confirmed sustained benefits, including better sensorimotor function and significantly lower neuropathology scores.
  • Phenobarbital treatment led to a significant reduction in ipsilateral cerebral hemisphere damage compared to saline controls.

Conclusions:

  • Early administration of phenobarbital can augment the neuroprotective efficacy of therapeutic hypothermia in a neonatal model.
  • This combined approach offers a potentially more effective strategy for mitigating brain injury following hypoxic-ischemic events.
  • Findings suggest a promising therapeutic avenue for improving outcomes in neonatal hypoxic-ischemic encephalopathy.

More Related Videos

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms05:00

Short-Duration Hypothermia Induction in Rats using Models for Studies examining Clinical Relevance and Mechanisms

Published on: March 3, 2021

Establishment of Deep Hypothermic Circulatory Arrest in Rats08:39

Establishment of Deep Hypothermic Circulatory Arrest in Rats

Published on: December 16, 2022

Related Concept Videos

Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in response to an infection or illness.